PATOU GARY
SEC CIK 1283535 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| XENE | Xenon Pharmaceuticals Inc. | Dir | 24.9K | — | $1.48M | 14 | 2021-12-08 | 2026-06-05 |
Most active insiders at XENE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | MORTIMER IAN | Pres, CEO, INTERIM CFO, Dir | — | $21.30M |
| 2 | KENNEY CHRISTOPHER JOHN | Chief Medical Off | — | $670.3K |
| 3 | GANNON STEVEN | Dir | — | $640.6K |
| 4 | DiFabio Andrea | CLO | — | $230.8K |
| 5 | PATOU GARY | Dir | — | $70.3K |
| 6 | Cannon Gillian | Dir | — | $63.2K |
| 7 | GAROFALO ELIZABETH A. | Dir | — | — |
| 8 | Gover Justin D. | Dir | — | — |
| 9 | Svoronos Dawn | Dir | — | — |
| 10 | Machado Patrick | Dir | — | — |
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-06-08 21:19 | 2026-06-05 | XENE | Xenon Pharmaceuticals Inc. | PATOU GARY | Dir | S - Sale | $53.14 | -1,322 | 24.9K | -5% | -$70.3K |
| D | 2026-06-03 21:04 | 2026-06-01 | XENE | Xenon Pharmaceuticals Inc. | PATOU GARY | Dir | M - OptEx | — | +2,645 | 26.2K | +11% | — |
| DM | 2024-11-22 | 2024-11-22 | XENE | Xenon Pharmaceuticals Inc. | PATOU GARY | Dir | M - OptEx | $10.24 | +6,586 | 26.7K | +33% | +$67.4K |
| DM | 2024-11-22 | 2024-11-22 | XENE | Xenon Pharmaceuticals Inc. | PATOU GARY | Dir | F - Tax | $39.80 | -1,695 | 25.6K | -6% | -$67.5K |
| DM | 2024-11-22 | 2024-11-22 | XENE | Xenon Pharmaceuticals Inc. | PATOU GARY | Dir | S - Sale+OE | $41.08 | -4,891 | 23.6K | -17% | -$200.9K |
| AI | 2023-12-15 | 2023-12-14 | XENE | Xenon Pharmaceuticals Inc. | PATOU GARY | Dir | S - Sale | $41.05 | -7,598 | 4,902 | -61% | -$311.9K |
| DM | 2023-12-15 | 2023-12-13 | XENE | Xenon Pharmaceuticals Inc. | PATOU GARY | Dir | S - Sale+OE | $39.29 | -11.4K | 23.6K | -33% | -$447.1K |
| DM | 2023-12-15 | 2023-12-13 | XENE | Xenon Pharmaceuticals Inc. | PATOU GARY | Dir | M - OptEx | $9.55 | +14.4K | 30.0K | +93% | +$137.5K |
| DM | 2023-12-15 | 2023-12-13 | XENE | Xenon Pharmaceuticals Inc. | PATOU GARY | Dir | F - Tax | $39.68 | -3,022 | 28.7K | -10% | -$119.9K |
| DI | 2023-12-15 | 2023-12-13 | XENE | Xenon Pharmaceuticals Inc. | PATOU GARY | Dir | S - Sale+OE | $41.05 | -7,598 | 4,902 | -61% | -$311.9K |
| DM | 2022-11-28 | 2022-11-23+ | XENE | Xenon Pharmaceuticals Inc. | PATOU GARY | Dir | S - Sale+OE | $34.55 | -3,994 | 23.6K | -14% | -$138.0K |
| D | 2022-11-28 | 2022-11-25 | XENE | Xenon Pharmaceuticals Inc. | PATOU GARY | Dir | F - Tax | $34.37 | -120 | 25.5K | -0.5% | -$4,124 |
| D | 2022-11-28 | 2022-11-25 | XENE | Xenon Pharmaceuticals Inc. | PATOU GARY | Dir | M - OptEx | $2.68 | +2,057 | 25.6K | +9% | +$5,513 |
| D | 2021-12-10 | 2021-12-08 | XENE | Xenon Pharmaceuticals Inc. | PATOU GARY | Dir | M - OptEx | $3.67 | +2,057 | 25.6K | +9% | +$7,549 |
Purchase Sale Sale after option exercise All abbreviations